seed
Stage
1
Investors
About
Rodos Biotargeting is a biotech company developing innovative drug delivery systems for targeted therapies. Their proprietary technology platform aims to precisely deliver active pharmaceutical ingredients to specific cells or tissues, primarily for oncology, inflammatory, and autoimmune disorders.
Explore Rodos Biotargeting's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.